Diabetic Retinopathy Market Size, Share, Growth Forecast 2024-2032

Diabetic Retinopathy Market

Diabetic Retinopathy Market by Type (Non-Proliferative Diabetic Retinopathy and Proliferative Diabetic Retinopathy) and by Management (Vitrectomy, Anti-VEGF Therapy, Laser Surgery, and Intraocular Steroid Injection): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2024 - 2032

Category: Healthcare Report Format : PDF Pages: 210 Report Code: ZMR-3504 Published Date: Feb-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 8.76 Billion USD 15.33 Billion 6.41% 2023

Diabetic Retinopathy Industry Prospective:

The global diabetic retinopathy market size was worth around USD 8.76 billion in 2023 and is predicted to grow to around USD 15.33 billion by 2032 with a compound annual growth rate (CAGR) of roughly 6.41% between 2024 and 2032.

Global Diabetic Retinopathy Market Size, 2032Request Free Sample

Market Overview

The report covers forecasts and analysis for the diabetic retinopathy market on a global and regional level. The study provides historical data from 2018 along with a forecast from 2024 to 2032 based on revenue (USD Billion). The study includes drivers and restraints for the diabetic retinopathy market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the diabetic retinopathy market on a global and regional level.

In order to give the users of this report a comprehensive view of the diabetic retinopathy market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein the Type segment is benchmarked based on its market size, growth rate, and general attractiveness.

Diabetic-Retinopathy-MarketRequest Free Sample

The report provides a company market share analysis in order to give a broader overview of the key players in the diabetic retinopathy market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new type launches, agreements, partnerships, collaborations & joint ventures, research& development, and regional expansion of major participants involved in the diabetic retinopathy market on a global and regional basis.

The study provides a decisive view of the diabetic retinopathy market by segmenting the market based on type, management, and region. The segments have been analyzed based on present and future trends and the market is estimated from 2024 to 2032. Based on the type, the diabetic retinopathy market has been segmented into non-proliferative diabetic retinopathy and proliferative diabetic retinopathy. Non-proliferative diabetic retinopathy segment holds the majority market share, due to the rising number of diabetic retinopathy patients and increasing awareness. The management segment includes vitrectomy, anti-VEGF therapy, laser surgery, and intraocular steroid injection. Anti-VEGF therapy segment holds the majority share of the management segment, due to its multiple benefits when compared to other therapies.

Diabetic Retinopathy Market: Report Scope

 

Report Attributes Report Details
Report Name Diabetic Retinopathy Market
Market Size in 2023 USD 8.76 Billion
Market Forecast in 2032 USD 15.33 Billion
Growth Rate CAGR of 6.41%
Number of Pages 210
Key Companies Covered Regeneron Pharmaceuticals, Novartis, Allergan, Genentech, Bayer AG, Aerpio Pharmaceuticals, BCN Peptides, Ampio Pharmaceuticals, ThromboGenics, Alimera Sciences, Kowa Company, and others.
Segments Covered By Type, By Management, and By Region
Regions Covered North America, Europe, Asia Pacific (APAC), Latin America, The Middle East and Africa (MEA)
Base Year 2023
Historical Year 2018 to 2022
Forecast Year 2024 - 2032
Customization Scope Avail customized purchase options to meet your exact research needs. Request For Customization

 

Region Analysis Preview

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa with its further bifurcation into major countries including the U.S., Canada, Germany, France, UK, China, Japan, India, and Brazil. This segmentation includes the demand for diabetic retinopathy based on individual segments and types in all regions and countries.

Diabetic Retinopathy Market: Competitive Analysis

The global diabetic retinopathy market is led by players like:

  • Regeneron Pharmaceuticals
  • Novartis
  • Allergan
  • Genentech
  • Bayer AG
  • Aerpio Pharmaceuticals
  • BCN Peptides
  • Ampio Pharmaceuticals
  • ThromboGenics
  • Alimera Sciences
  • Kowa Company

This report segments the global diabetic retinopathy market as follows:

Global Diabetic Retinopathy Market: By Type

  • Non-Proliferative Diabetic Retinopathy
  • Proliferative Diabetic Retinopathy

Global Diabetic Retinopathy Market: By Management

  • Vitrectomy
  • Anti-VEGF Therapy
  • Laser Surgery
  • Intraocular Steroid Injection

Global Diabetic Retinopathy Market: By Region

  • North America
    • The U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

Table Of Content

Methodology

Free Analysis

FrequentlyAsked Questions

Diabetic retinopathy is a complication that affects the eyes of diabetic people. Incessant elevated blood sugar due to diabetes is linked with impairment of small blood vessels present in the retina. Diabetic retinopathy can induce retinal blood vessels to hemorrhage or cause fluid leakage.

According to the report, the global diabetic retinopathy market size was worth around USD 8.76 billion in 2023 and is expected to reach around USD 15.33 billion by 2032.

The global diabetic retinopathy market is expected to grow at a CAGR of 6.41% during the forecast period.

North America is expected to dominate the diabetic retinopathy market over the forecast period.

The global diabetic retinopathy market is dominated by players like Regeneron Pharmaceuticals, Novartis, Allergan, Genentech, Bayer AG, Aerpio Pharmaceuticals, BCN Peptides, Ampio Pharmaceuticals, ThromboGenics, Alimera Sciences, and Kowa Company, among others.

The diabetic retinopathy market report covers the geographical market along with a comprehensive competitive landscape analysis. It also includes cash flow analysis, profit ratio analysis, market basket analysis, market attractiveness analysis, sentiment analysis, PESTLE analysis, trend analysis, SWOT analysis, trade area analysis, demand & supply analysis, Porter’s five forces analysis, and value chain analysis.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed